Another reimbursement restriction in Germany
Most medicines are reimbursed at 100% from the day of launch in Germany, i.e. coverage by SHI funds is granted with the marketing authorization
Category: News and updates
Why did the G-BA assess Trimbow now?
Trimbow was launched onto the German market in 2017. So why did the G-BA assess its benefit now? You likely know that
Change in morbidity factor means more GPs are needed in Germany
Identifying amount of required healthcare The G-BA developed the needs planning directive (German: Bedarfsplanungs-Richtlinie) to give national rules on “how much” SHI-funded
Pricing of generics in Germany: Are there any rules?
The process of determining the reimbursed price of a product with a new chemical entity is clearly defined and follows specific steps.
Wound treatment: bandage material or other products – an important difference for reimbursement
Wound treatment materials and products are considered medical devices. The GVWG (§31 (1a) SGB V) from 2 December 2020 introduced a new